Balanced news tone
News Sentiment
FORTE sentiment intelligence
Forte Bilgi Iletisim Teknolojileri ve Savunma Sanayi A.S. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
49
Balanced news tone
19 relevant articles
News tone and price action are not far from neutral.
93/100 classification confidence.
directly relevant articles
high-authority source matches
+2.7% over one week, +4.3% over four weeks, trend inactive, and materially above fair value.
Forte Biosciences (FBRX) CFO receives 22,000 stock options grant
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
93/100 classification
One-week reaction
2.7%
Price confirming higher
Trend fit
Trend inactive
4.3% over four weeks
Fair value
31.9%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
0
Neutral
17
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Stock Titan
Direct company coverage
Forte Biosciences (FBRX) CFO receives 22,000 stock options grant
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 20:55
- Source
- Stock Titan
Stock Titan
Direct company coverage
Forte Biosciences (FBRX) awards 500,000 stock options to insider Wagner
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 20:54
- Source
- Stock Titan
TradingKey
Direct company coverage
Forte Biosciences Inc (FBRX) Dividends & Stock Splits: Historical Payouts and Event Timeline
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 15:51
- Source
- TradingKey
Market source
Direct company coverage
One Forte Biosciences Insider Raised Stake By 30% In Previous Year
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 13 Jun 2026 13:24
- Source
- Market source
Stock Titan
Direct company coverage
Forte Biosciences (NASDAQ: FBRX) files $500M shelf to sell securities
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Forte Biosciences (NASDAQ: FBRX) director receives 18,353 RSU equity award
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Forte Biosciences (FBRX) director granted 18,353 RSUs in equity award
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Forte Biosciences (FBRX) director awarded 18,353 RSUs vesting after 2026 meeting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Forte Biosciences (FBRX) director awarded 18,353 restricted stock units in equity grant
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Director at Forte Biosciences (NASDAQ: FBRX) awarded 18,353 RSUs as equity grant
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Forte Biosciences (FBRX) stockholders approve amended 2021 equity incentive plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Stock Titan
Mshale
Direct company coverage
Fundstrat's Tom Lee: Stock Market Is Getting Stronger Allerta Per Vento Forte (9Ck6HxHVcV)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 May 2026 09:27
- Source
- Mshale
simplywall.st
Direct company coverage
Forte Biosciences Slides As Insider Purchases Lose Another US$70k
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 May 2026 07:00
- Source
- simplywall.st
Seeking Alpha
Direct company coverage
Forte Biosciences Stock: Targeting Celiac Disease (NASDAQ:FBRX)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 May 2026 07:00
- Source
- Seeking Alpha
Investing.com
Direct company coverage
Forte Biosciences launches public stock offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Apr 2026 07:00
- Source
- Investing.com
Stock Titan
Direct company coverage
Drug developer Forte launches stock sale to fund clinical research
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Apr 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
New hires at Forte Biosciences get options on 25,000 shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Mar 2026 07:00
- Source
- Stock Titan
simplywall.st
Direct company coverage
Institutional investors may adopt severe steps after Forte Biosciences, Inc.'s (NASDAQ:FBRX) latest 15% drop adds to a year losses
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 03 Jan 2026 08:00
- Source
- simplywall.st
Stock Titan
Direct company coverage
Forte Biosciences (NASDAQ: FBRX) approves Nasdaq Rule 5635(c)(4) inducement option grant
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Nov 2025 08:00
- Source
- Stock Titan